• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interferon with Dogma in Cytokine Release Syndrome and Acute Lung Injury.

作者信息

Denstaedt Scott J, Zemans Rachel L

机构信息

Department of Internal Medicine University of Michigan Medical School Ann Arbor, Michigan.

出版信息

Am J Respir Cell Mol Biol. 2023 Jan;68(1):7-8. doi: 10.1165/rcmb.2022-0396ED.

DOI:10.1165/rcmb.2022-0396ED
PMID:36260489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9817913/
Abstract
摘要

相似文献

1
Interferon with Dogma in Cytokine Release Syndrome and Acute Lung Injury.细胞因子释放综合征和急性肺损伤中的干扰素与教条
Am J Respir Cell Mol Biol. 2023 Jan;68(1):7-8. doi: 10.1165/rcmb.2022-0396ED.
2
IFN- Is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury.IFN- 在细胞因子释放综合征相关的肺外急性肺损伤中具有保护作用。
Am J Respir Cell Mol Biol. 2023 Jan;68(1):75-89. doi: 10.1165/rcmb.2022-0117OC.
3
Off balance: Interferons in COVID-19 lung infections.失衡：细胞因子在 COVID-19 肺部感染中的作用。
EBioMedicine. 2021 Nov;73:103642. doi: 10.1016/j.ebiom.2021.103642. Epub 2021 Oct 19.
4
Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19.化湿败毒方通过抑制细胞因子风暴减轻脓毒症诱导的急性肺损伤：治疗 COVID-19 的意义。
Phytomedicine. 2023 Jan;109:154549. doi: 10.1016/j.phymed.2022.154549. Epub 2022 Nov 19.
5
Cytokine Storm-Definition, Causes, and Implications.细胞因子风暴-定义、原因及影响。
Int J Mol Sci. 2022 Oct 3;23(19):11740. doi: 10.3390/ijms231911740.
6
Polyphosphazene nanodrugs for targeting delivery and inflammation responsive release of curcumin to treat acute lung injury by effectively inhibiting cytokine storms.聚膦腈纳米药物通过有效抑制细胞因子风暴靶向递送和炎症响应释放姜黄素治疗急性肺损伤。
Colloids Surf B Biointerfaces. 2023 Sep;229:113446. doi: 10.1016/j.colsurfb.2023.113446. Epub 2023 Jul 7.
7
SARS-CoV-2 and lung injury: Dysregulation of immune response but not hyperimmune response as in "cytokine storm syndrome".SARS-CoV-2 与肺部损伤：免疫反应失调而非“细胞因子风暴综合征”中的过度免疫反应。
Clin Respir J. 2022 Jan;16(1):13-16. doi: 10.1111/crj.13455. Epub 2021 Nov 3.
8
Effects of tocilizumab and dexamethasone on the downregulation of proinflammatory cytokines and upregulation of antioxidants in the lungs in oleic acid-induced ARDS.托珠单抗和地塞米松对油酸诱导的 ARDS 中肺内促炎细胞因子下调和抗氧化剂上调的影响。
Respir Res. 2022 Sep 17;23(1):249. doi: 10.1186/s12931-022-02172-w.
9
Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury.小分子抑制剂 CRT0066101 可抑制肺损伤小鼠模型中的细胞因子风暴综合征。
Int Immunopharmacol. 2023 Jul;120:110240. doi: 10.1016/j.intimp.2023.110240. Epub 2023 May 12.
10
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.固有受体激活模式涉及 COVID-19、ALI/ARDS 和脓毒症细胞因子风暴中的 TLR 和 NLR 协同作用：综述和模型制作新的预测和治疗建议。
Int J Mol Sci. 2021 Feb 20;22(4):2108. doi: 10.3390/ijms22042108.

引用本文的文献

1
Pathogenesis, Diagnosis, and Management of Cytokine Release Syndrome in Patients with Cancer: Focus on Infectious Disease Considerations.癌症患者细胞因子释放综合征的发病机制、诊断与管理：聚焦传染病相关考量
Curr Oncol. 2025 Mar 28;32(4):198. doi: 10.3390/curroncol32040198.

本文引用的文献

1
IFN- Is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury.IFN- 在细胞因子释放综合征相关的肺外急性肺损伤中具有保护作用。
Am J Respir Cell Mol Biol. 2023 Jan;68(1):75-89. doi: 10.1165/rcmb.2022-0117OC.
2
Interferon-γ promotes monocyte-mediated lung injury during influenza infection.干扰素-γ 在流感感染期间促进单核细胞介导的肺损伤。
Cell Rep. 2022 Mar 1;38(9):110456. doi: 10.1016/j.celrep.2022.110456.
3
Potential Role of IFNγ Inhibition in Refractory Cytokine Release Syndrome Associated with CAR T-cell Therapy.IFNγ 抑制在 CAR T 细胞治疗相关难治性细胞因子释放综合征中的潜在作用。
Blood Cancer Discov. 2022 Mar 1;3(2):90-94. doi: 10.1158/2643-3230.BCD-21-0203.
4
Critical care management of chimeric antigen receptor T-cell therapy recipients.嵌合抗原受体 T 细胞治疗受者的重症监护管理。
CA Cancer J Clin. 2022 Jan;72(1):78-93. doi: 10.3322/caac.21702. Epub 2021 Oct 6.
5
IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome.IFN-γ 在巨噬细胞活化综合征中肺泡巨噬细胞驱动的肺部炎症中是必不可少的。
JCI Insight. 2021 Sep 8;6(17):e147593. doi: 10.1172/jci.insight.147593.
6
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
7
"Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.“小”肠道免疫病理学在致死性细胞因子释放综合征中发挥“大”作用，其可通过干扰素-γ、IL-17A 和一种 Janus 激酶抑制剂进行调节。
Front Immunol. 2020 Jun 26;11:1311. doi: 10.3389/fimmu.2020.01311. eCollection 2020.
8
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗？
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
9
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.埃马珠单抗治疗原发性噬血细胞性淋巴组织细胞增生症患儿。
N Engl J Med. 2020 May 7;382(19):1811-1822. doi: 10.1056/NEJMoa1911326.
10
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.美国传染病学会关于2019冠状病毒病患者治疗与管理的指南
Clin Infect Dis. 2020 Apr 27. doi: 10.1093/cid/ciaa478.